TransMedics Share Holder Equity 2019-2024 | TMDX
TransMedics share holder equity from 2019 to 2024. Share holder equity can be defined as the sum of preferred and common equity items
| TransMedics Annual Share Holder Equity (Millions of US $) |
|
|---|---|
| 2024 | $229 |
| 2023 | $137 |
| 2022 | $187 |
| 2021 | $68 |
| 2020 | $104 |
| 2019 | $55 |
| 2018 | $-6 |
| TransMedics Quarterly Share Holder Equity (Millions of US $) |
|
|---|---|
| 2024-12-31 | $229 |
| 2024-09-30 | $210 |
| 2024-06-30 | $190 |
| 2024-03-31 | $159 |
| 2023-12-31 | $137 |
| 2023-09-30 | $126 |
| 2023-06-30 | $145 |
| 2023-03-31 | $193 |
| 2022-12-31 | $187 |
| 2022-09-30 | $188 |
| 2022-06-30 | $51 |
| 2022-03-31 | $60 |
| 2021-12-31 | $68 |
| 2021-09-30 | $79 |
| 2021-06-30 | $89 |
| 2021-03-31 | $98 |
| 2020-12-31 | $104 |
| 2020-09-30 | $110 |
| 2020-06-30 | $114 |
| 2020-03-31 | $47 |
| 2019-12-31 | $55 |
| 2019-09-30 | $63 |
| 2019-06-30 | $71 |
| 2019-03-31 | $-13 |
| 2018-12-31 | $-6 |
| 2018-09-30 | $0 |
| 2018-06-30 | $0 |
| 2018-03-31 | $0 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MED INSTRUMENTS | $3.043B | $0.442B |
| TransMedics Inc. is a commercial-stage medical technology company. It is engaged in transforming organ transplant therapy for end-stage organ failure patients. The company offers Organ Care System, an integrated, compact, portable preservation technology which addresses unmet need for organs for transplantation. TransMedics Inc. is headquartered in Andover, Massachusetts. | |||